Table 2 Summary of codeml tests for positive selection of toxins from venom-gland transcriptome in H. curtus
Toxins (No.) | M1: Nearly neutral | -lnL | M2: Positive selection | -lnL | M0: ω | Δa | P-valueb | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
3-FTx (1, 2, 3) | p: | 0.28 | 0.72 | 748.17 | p: | 0.17 | 0.39 | 0.45 | 735.24 | 2.81 | 25.86 | 2.4 × 10−6* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 6.13 | ||||||
3-FTx (4) | p: | 0.26 | 0.74 | 804.61 | p: | 0.05 | 0.52 | 0.43 | 783.22 | 3.48 | 42.78 | 5.1 × 10−10* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 8.76 | ||||||
3-FTx (5) | p: | 0.51 | 0.49 | 652.06 | p: | 0.35 | 0.37 | 0.28 | 632.67 | 2.86 | 38.78 | 3.8 × 10−9* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 9.59 | ||||||
CTL (1) | p: | 0.30 | 0.70 | 843.02 | p: | 0.19 | 0.74 | 0.06 | 840.70 | 0.21 | 4.64 | 0.10 |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 24.33 | ||||||
CTL (2) | p: | 0.64 | 0.36 | 1221.13 | p: | 0.84 | 0.00 | 0.16 | 1212.49 | 0.58 | 17.28 | 1.8 × 10−4* |
ω: | 0.05 | 1.00 | ω: | 0.22 | 1.00 | 3.50 | ||||||
CTL (3) | p: | 0.15 | 0.85 | 1160.65 | p: | 0.40 | 0.00 | 0.60 | 1148.75 | 2.43 | 23.80 | 6.8 × 10−6* |
ω: | 0.00 | 1.00 | ω: | 0.17 | 1.00 | 4.52 | ||||||
CTL (4) | p: | 0.53 | 0.47 | 1201.51 | p: | 0.50 | 0.44 | 0.07 | 1196.01 | 0.65 | 11.00 | 0.004 |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 4.91 | ||||||
PLA2 (1) | p: | 0.49 | 0.51 | 978.57 | p: | 0.68 | 0.00 | 0.32 | 973.82 | 0.86 | 9.50 | 0.009 |
ω: | 0.00 | 1.00 | ω: | 0.13 | 1.00 | 3.17 | ||||||
PLA2 (2, 3) | p: | 0.44 | 0.56 | 967.20 | p: | 0.60 | 0.00 | 0.40 | 949.47 | 2.08 | 35.46 | 2.0 × 10−8* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 6.87 | ||||||
SVMP (1) | p: | 0.34 | 0.66 | 4316.80 | p: | 0.85 | 0.00 | 0.15 | 4292.41 | 1.08 | 48.78 | 2.6 × 10−11* |
ω: | 0.00 | 1.00 | ω: | 0.57 | 1.00 | 5.53 | ||||||
SVMP (2) | p: | 0.51 | 0.49 | 7561.33 | p: | 0.35 | 0.47 | 0.18 | 7411.20 | 1.30 | 300.26 | 0.00* |
ω: | 0.05 | 1.00 | ω: | 0.00 | 1.00 | 5.65 | ||||||
SVSP (1) | p: | 0.47 | 0.53 | 2042.88 | p: | 0.41 | 0.55 | 0.04 | 2028.38 | 0.73 | 29.00 | 5.0 × 10−7* |
ω: | 0.01 | 1.00 | ω: | 0.00 | 1.00 | 7.78 | ||||||
SVSP (2) | p: | 0.46 | 0.54 | 3659.22 | p: | 0.30 | 0.47 | 0.23 | 3579.72 | 2.25 | 159.00 | 0.00* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 9.49 | ||||||
5NT (1, 2) | p: | 0.66 | 0.34 | 3064.74 | p: | 0.89 | 0.06 | 0.05 | 3057.77 | 0.40 | 13.94 | 9.4 × 10−4* |
ω: | 0.00 | 1.00 | ω: | 0.19 | 1.00 | 6.10 | ||||||
CRISP (1, 2) | p: | 0.43 | 0.57 | 2473.69 | p: | 0.28 | 0.56 | 0.16 | 2428.77 | 1.63 | 89.84 | 0.00* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 6.69 | ||||||
NGF (1, 2, 3) | p: | 0.54 | 0.46 | 2549.71 | p: | 0.60 | 0.30 | 0.10 | 2527.86 | 0.86 | 43.70 | 3.2 × 10−10* |
ω: | 0.12 | 1.00 | ω: | 0.28 | 1.00 | 4.35 | ||||||
Cystatin | p: | 0.49 | 0.51 | 823.89 | p: | 0.93 | 0.00 | 0.07 | 816.20 | 0.94 | 15.38 | 4.6 × 10−4* |
ω: | 0.00 | 1.00 | ω: | 0.48 | 1.00 | 7.57 | ||||||
HA | p: | 0.52 | 0.48 | 3349.08 | p: | 0.56 | 0.00 | 0.44 | 3347.91 | 0.54 | 2.34 | 0.31 |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 1.28 | ||||||
PDE | p: | 0.54 | 0.46 | 5504.07 | p: | 0.57 | 0.31 | 0.12 | 5488.82 | 0.65 | 30.50 | 2.4 × 10−7* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 3.57 | ||||||
PLA2 inhibitor | p: | 0.49 | 0.51 | 1905.45 | p: | 0.50 | 0.00 | 0.49 | 1905.43 | 0.48 | 0.04 | 0.98 |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 1.06 | ||||||
PLB | p: | 0.55 | 0.45 | 4016.84 | p: | 0.51 | 0.46 | 0.02 | 4001.61 | 0.58 | 30.46 | 2.4 × 10−7* |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 7.11 | ||||||
QC | p: | 0.77 | 0.23 | 2219.42 | p: | 0.78 | 0.00 | 0.22 | 2219.39 | 0.22 | 0.06 | 0.97 |
ω: | 0.00 | 1.00 | ω: | 0.00 | 1.00 | 1.08 | ||||||
VEGF | p: | 0.38 | 0.62 | 1221.70 | p: | 0.64 | 0.30 | 0.05 | 1214.99 | 0.82 | 13.42 | 1.2 × 10−3* |
ω: | 0.00 | 1.00 | ω: | 0.43 | 1.00 | 7.44 | ||||||